Intravenous Securement Device Sales

Intravenous Securement Device Sales Market Outlook

The global intravenous securement device sales market is projected to reach approximately USD 3.4 billion by 2025, with a compound annual growth rate (CAGR) of 8.2% from 2023 to 2030. This growth is primarily driven by the increasing prevalence of chronic diseases, which require frequent intravenous therapies and the rising number of surgical procedures across the globe. Furthermore, advancements in medical technology and the growing focus on minimizing catheter-related complications are propelling the demand for securement devices. The emphasis on improving patient safety and enhancing the overall efficiency of healthcare services is also a significant contributing factor. As healthcare providers continue to prioritize the quality of patient care, the intravenous securement device market is expected to witness robust growth in the coming years.

Growth Factor of the Market

The growth of the intravenous securement device sales market can be attributed to several key factors. Firstly, the increasing incidence of chronic diseases such as diabetes, cancer, and cardiovascular disorders necessitates long-term intravenous therapy, thereby boosting the demand for effective securement devices. Moreover, the rise in the geriatric population, who often require healthcare interventions involving intravenous methods, is further fueling market expansion. Additionally, advancements in material science and technology have led to the development of innovative securement devices that enhance patient comfort and minimize the risk of infections, which are critical considerations within healthcare settings. The growing preference for outpatient surgical procedures also plays a role, as these settings require reliable and efficient securement solutions to ensure patient safety post-operation. Furthermore, the focus on reducing overall healthcare costs by minimizing complications associated with intravenous therapy is driving healthcare providers to adopt more secure and reliable devices.

Key Highlights of the Market

• The market is driven by rising demand for chronic disease management and surgical procedures requiring intravenous access.
• Technological advancements in securement devices are enhancing patient safety and comfort.
• Growing preference for outpatient care is increasing the need for effective intravenous securement solutions.
• Significant investments in healthcare infrastructure are expected to support market growth.
• The market is witnessing a trend towards the integration of securement devices with other medical technologies to improve outcomes.

By Product Type

Adhesive Securement Devices:

Adhesive securement devices are designed to hold catheters and other intravenous lines in place using a flexible adhesive material. These devices have gained popularity due to their ease of use and effectiveness in preventing catheter dislodgement. They typically feature various designs and sizes to accommodate different types of intravenous lines, ensuring a secure hold regardless of the patient's mobility. The adhesive nature of these devices minimizes the risk of irritation and skin breakdown, making them suitable for prolonged use. Additionally, the rise in minimally invasive procedures and outpatient care settings has further increased the demand for adhesive securement devices, as they provide a convenient solution for healthcare providers and enhance patient comfort. Manufacturers are continually innovating adhesive technologies to improve adhesion strength while ensuring skin compatibility, which is expected to drive this segment's growth in the market.

Mechanical Securement Devices:

Mechanical securement devices use physical mechanisms to hold intravenous lines in place, providing an alternative to adhesive-based devices. This type of securement solution often incorporates clamps or clips that can be adjusted to maintain the catheter's position securely. Mechanical devices are especially beneficial for patients who may experience skin sensitivities or allergic reactions to adhesives. They provide a reliable option for securement without the risk of adhesive-related complications. The mechanical securement device segment is expected to grow as healthcare providers increasingly recognize the need for versatile solutions that can accommodate various patient populations and therapeutic interventions. Furthermore, the introduction of user-friendly designs and materials that are easier to clean and maintain is anticipated to enhance the adoption of mechanical securement devices across healthcare settings.

Integrated Securement Devices:

Integrated securement devices combine both securement and access features into a single unit, streamlining the intravenous therapy process. These devices often include built-in valves or ports that allow for multiple access points, reducing the need for additional punctures and minimizing the risk of complications such as infection. Integrated securement devices are particularly advantageous in emergency and surgical settings, where time is of the essence, and efficiency is paramount. This segment is expected to see significant growth as the healthcare industry continues to seek innovative solutions that enhance workflow and patient care. Additionally, as more healthcare systems adopt integrated approaches to intravenous therapy, the demand for these advanced securement devices will likely escalate, driven by their ability to improve outcomes and reduce procedural risks.

Securement Strips:

Securement strips are specialized devices designed to provide additional support and stability for intravenous lines by wrapping around the catheter and securing it to the skin. These strips are particularly useful in situations where traditional adhesive solutions may not provide sufficient security, such as during patient movement or in cases where the catheter is subject to tension. The flexibility and adjustability of securement strips allow for a customizable fit, accommodating varying patient sizes and clinical scenarios. As the healthcare industry increasingly prioritizes patient safety and the prevention of catheter-related complications, the demand for securement strips is expected to rise. Furthermore, innovations in material technology are enhancing the effectiveness of securement strips by improving their adhesion properties and comfort levels, thereby contributing to the overall growth of this product segment.

Securement Dressings:

Securement dressings serve as a protective layer over the intravenous catheter site, preventing contamination and reducing the risk of infection. These dressings are designed to be transparent, allowing for easy visualization of the insertion site while providing a barrier against external contaminants. The growing awareness of hospital-acquired infections (HAIs) has heightened the demand for securement dressings that emphasize both securement and infection prevention. As healthcare providers implement stringent protocols to enhance patient safety, securement dressings are becoming integral to intravenous therapy management. Additionally, the development of antimicrobial and hypoallergenic dressings is further driving the segment's growth, as they offer enhanced protection and comfort for patients, particularly those with sensitive skin or a history of allergic reactions.

By Application

Hospitals:

Hospitals represent one of the largest application segments for intravenous securement devices due to the high volume of surgical procedures and treatments requiring intravenous access. In hospital settings, securement devices are critical for ensuring the safety and efficacy of intravenous therapy, as they help prevent complications such as catheter dislodgement and infections. The increasing number of patients undergoing surgeries, especially minimally invasive procedures, necessitates the use of securement devices to maintain catheter stability. Moreover, hospitals are implementing best practices in infection control, further boosting the demand for advanced securement solutions that align with regulatory standards. As hospitals continue to prioritize patient safety and quality of care, the intravenous securement device market's growth will be significantly influenced by innovations tailored to meet the unique needs of hospital environments.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are gaining traction in the healthcare landscape, providing cost-effective alternatives to traditional inpatient surgery. The demand for intravenous securement devices in ASCs is growing as these facilities perform increasing numbers of outpatient procedures requiring intravenous access. The ability to safely secure catheters during minimally invasive surgeries without extended hospital stays necessitates the use of reliable securement solutions. Furthermore, as ASCs prioritize patient satisfaction and safety, the adoption of advanced securement devices is expected to rise. The shift towards outpatient care is projected to drive the growth of the intravenous securement device market within this application segment, as providers seek to enhance patient experiences while minimizing complications associated with intravenous therapy.

Clinics:

Clinics, which include a wide range of healthcare facilities such as urgent care centers and specialty clinics, are increasingly utilizing intravenous securement devices for various treatments. The rise in chronic disease management and preventive care initiatives is generating demand for reliable intravenous access in clinics. Securement devices are essential for ensuring that patients receive care without complications, particularly for long-term therapies such as chemotherapy and infusions. As patient traffic in clinics increases, the adoption of effective securement solutions is expected to follow suit. Additionally, the growing emphasis on patient-centered care in clinical settings is prompting healthcare providers to integrate advanced securement devices that enhance the overall treatment experience, further driving market growth.

Homecare Settings:

The expansion of home healthcare services is creating new opportunities for intravenous securement devices, especially as more patients opt for receiving care in the comfort of their homes. Homecare settings require securement solutions that ensure the safety and effectiveness of intravenous therapy while accommodating the unique challenges of administering care outside traditional healthcare facilities. Devices that are easy to use and provide effective securement are crucial for caregivers and family members managing patients at home. The aging population, coupled with the increasing prevalence of chronic diseases, is propelling the demand for homecare solutions, including intravenous securement devices. As the concept of home healthcare continues to evolve, the market is likely to see significant growth in this segment, driven by innovations that cater specifically to homecare needs.

Others:

This category encompasses various settings where intravenous securement devices are utilized outside traditional healthcare environments, such as in rehabilitation centers and nursing homes. The demand for securement devices in these settings is driven by the need for effective management of intravenous therapy for patients undergoing rehabilitation or long-term care. As healthcare facilities increasingly prioritize patient safety and comfort, the use of securement devices is becoming essential to prevent complications and enhance therapy success rates. The diverse range of applications within this segment presents an opportunity for manufacturers to develop and market specialized securement solutions tailored to the unique needs of different patient populations and settings, paving the way for growth in the intravenous securement device market.

By Distribution Channel

Direct Sales:

Direct sales channels involve manufacturers selling intravenous securement devices directly to healthcare providers and institutions. This approach allows companies to foster strong relationships with their clients and gain valuable insights into their needs and preferences. Direct sales can be particularly effective for introducing new products, as it enables manufacturers to provide education and training to healthcare staff on device usage and best practices. This distribution channel is expected to grow as healthcare organizations increasingly seek customized solutions and partnerships with manufacturers that prioritize quality and reliability. Furthermore, direct sales facilitate quick access to new technologies, enhancing the overall efficiency of procurement and ensuring that healthcare providers can respond swiftly to patient needs.

Distributors:

Distributors play a pivotal role in the intravenous securement device market by serving as intermediaries between manufacturers and healthcare facilities. They provide a wide range of products from multiple brands, allowing healthcare providers to access various securement solutions in one place. This distribution model is particularly advantageous for smaller healthcare facilities that may not have the resources to engage directly with multiple manufacturers. Distributors also offer essential support services, such as inventory management and logistics, ensuring that healthcare providers can maintain a consistent supply of securement devices. As the market continues to evolve, distributor partnerships are expected to expand, offering manufacturers enhanced market reach and healthcare providers greater convenience in sourcing the necessary securement solutions.

By Material Type

Silicone:

Silicone is one of the most commonly used materials in the production of intravenous securement devices due to its biocompatibility and flexibility. Silicone-based securement devices provide excellent durability and resistance to wear, making them suitable for prolonged use in various healthcare settings. Their skin-friendly properties minimize the risk of irritation and allergic reactions, which is especially important for patients with sensitive skin. The growing recognition of the benefits of silicone materials is driving the demand for silicone-based securement devices, particularly in hospitals and outpatient care facilities. Additionally, ongoing advancements in silicone technology are leading to the development of products that enhance patient comfort while maintaining securement effectiveness, further propelling the growth of this segment.

Polyurethane:

Polyurethane is another popular material used in the manufacturing of intravenous securement devices, known for its strength and versatility. Devices made from polyurethane exhibit excellent adhesive properties and are often designed to provide secure attachment without compromising patient comfort. This material is particularly advantageous in environments where moisture management is crucial, as it helps to prevent skin breakdown and infections. The increasing focus on infection control within healthcare settings is driving the adoption of polyurethane securement devices, as they are engineered to provide a secure barrier against contaminants. As manufacturers continue to innovate with polyurethane formulations and designs, the demand for these devices is expected to expand significantly.

Acrylic:

Acrylic materials are also utilized in the production of intravenous securement devices, offering clear visibility of the insertion site while providing reliable securement. Acrylic-based devices are lightweight and often feature a transparent design, allowing healthcare providers to monitor the catheter site easily. This transparency is particularly valuable in settings where quick assessments of the insertion site are necessary. Although less commonly used than silicone and polyurethane, acrylic securement devices are gaining traction due to their unique properties and benefits. The segment is anticipated to grow as healthcare facilities recognize the advantages of acrylic materials in enhancing patient safety and improving clinical outcomes through better visual monitoring.

Others:

This category includes various alternative materials used in the development of intravenous securement devices, such as thermoplastics and specialized composites. The use of these materials is often driven by the need for specific properties, such as enhanced flexibility, improved adherence, or antimicrobial features. As the intravenous securement device market evolves, manufacturers are exploring innovative material combinations that can provide superior performance and meet the growing demands of healthcare providers. The ongoing research and development in this area are expected to drive market growth as new materials are introduced, offering enhanced functionality and better outcomes for patients undergoing intravenous therapy.

By Region

In North America, the intravenous securement device sales market is projected to dominate, accounting for a significant share of the global market due to the advanced healthcare infrastructure and high prevalence of chronic diseases. The region is expected to witness a CAGR of 9.0% from 2023 to 2030, driven by the increasing demand for outpatient surgical procedures and the adoption of advanced medical technologies. Moreover, the presence of major market players and the continuous innovations in securement devices contribute to the robust growth in this region. As healthcare providers in North America prioritize patient safety and infection control, the demand for effective securement solutions will continue to rise, solidifying North America's leadership position in the global market.

Europe is another key region in the intravenous securement device sales market, characterized by a strong emphasis on patient safety and quality healthcare. The European market is anticipated to grow steadily as healthcare facilities increasingly adopt protocols aimed at minimizing complications associated with intravenous therapy. The implementation of stringent regulations regarding infection control and patient care standards is expected to bolster the demand for advanced securement devices. Additionally, the growing geriatric population and the prevalence of chronic diseases in Europe underline the need for effective intravenous solutions. As a result, the European market is expected to exhibit moderate growth, aligning with the overall upward trend in healthcare investments across the region.

Opportunities

The intravenous securement device market is poised for significant opportunities driven by several factors. Firstly, the increasing trend of outpatient care is encouraging healthcare providers to seek efficient and reliable securement solutions that enhance patient safety and comfort. This shift not only provides cost savings for healthcare systems but also emphasizes the importance of reducing hospital stays and complications associated with intravenous therapy. Additionally, advancements in technology present opportunities for manufacturers to explore innovative product designs and materials, catering to the evolving needs of healthcare providers and patients alike. The integration of smart technology into securement devices, such as sensors for monitoring and alerting caregivers of potential issues, could revolutionize patient care and further drive market growth.

Furthermore, the growing emphasis on preventive healthcare measures and chronic disease management creates a substantial market opportunity for intravenous securement devices. As more patients require long-term intravenous therapy, the demand for securement solutions that prioritize patient safety and minimize complications is expected to increase. Manufacturers who focus on research and development to create high-quality, effective products will find significant opportunities to expand their market presence. Collaborations with healthcare institutions to gain insights into clinical needs and patient experiences can also lead to the development of tailored securement solutions that address specific challenges, positioning companies for success in this dynamic market.

Threats

Despite the promising growth prospects for the intravenous securement device market, several threats could impact its trajectory. One significant threat is the increasing competition among manufacturers, which may lead to price wars and reduced profit margins. As new players enter the market and existing companies strive to innovate, there is a risk that the focus on cost reduction could overshadow the importance of quality and safety. Additionally, the rapid pace of technological advancements in healthcare may render certain products obsolete if manufacturers do not adapt quickly to emerging trends and customer expectations. Furthermore, regulatory challenges and the need for compliance with stringent quality standards could pose hurdles for manufacturers, especially smaller companies that may lack the resources to navigate complex regulatory environments.

Another potential threat is the rising incidence of healthcare-associated infections (HAIs), which has triggered increased scrutiny of medical devices, including intravenous securement solutions. As healthcare providers implement stricter infection control measures, there is a risk that certain products may face higher scrutiny or even withdrawal from the market if they are associated with adverse outcomes. This focus on infection prevention necessitates continuous innovation and improvement within the industry, as manufacturers must ensure that their products effectively address current healthcare challenges. Therefore, companies that fail to keep pace with evolving requirements and market demands may find themselves at a competitive disadvantage.

Competitor Outlook

• 3M Company
• Smith & Nephew plc
• BD (Becton, Dickinson and Company)
• Medtronic plc
• Teleflex Incorporated
• Fresenius Kabi AG
• Terumo Corporation
• Braun Melsungen AG
• Hollister Incorporated
• ConvaTec Group plc
• SkinSmart Solutions
• Halyard Health, Inc.
• Cardinal Health, Inc.
• Wound Care Technologies, Inc.
• Adapta Medical Solutions

The competitive landscape of the intravenous securement device market is characterized by a mix of established players and new entrants vying for market share. Major companies are focusing on product diversification and innovation to maintain their positions in the market. Strategies such as mergers and acquisitions, partnerships, and collaborations are becoming increasingly common as companies seek to enhance their offerings and leverage complementary strengths. As the demand for advanced securement solutions continues to grow, companies are investing in research and development to bring forth innovative products that address the evolving needs of healthcare providers and patients. Furthermore, companies are prioritizing sustainability and environmentally friendly practices in their product development, aligning with the global trend towards eco-conscious healthcare solutions.

Among the leading competitors in the intravenous securement device market, 3M Company stands out for its extensive portfolio of innovative medical products and commitment to quality. The company's advanced adhesive technologies and securement solutions are widely used in healthcare settings, making it a trusted name among healthcare providers. Similarly, BD (Becton, Dickinson and Company) has established itself as a key player in the market, offering a comprehensive range of securement devices designed to enhance patient safety and minimize complications. The company's emphasis on research and development has led to the introduction of cutting-edge products that cater to specific clinical needs, solidifying its market position.

Teleflex Incorporated is another major player in the intravenous securement device market, known for its focus on patient-centered solutions. The company's commitment to innovation is evident in its diverse range of securement products, which are designed to improve patient outcomes and streamline clinical workflows. Additionally, Medtronic plc is recognized for its expertise in medical technologies, including securement devices, and has made significant strides in integrating smart technologies into its product offerings. As the market continues to evolve, these companies and others are well-positioned to capitalize on emerging trends and drive growth in the intravenous securement device market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 3M Company
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Medtronic plc
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Fresenius Kabi AG
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Braun Melsungen AG
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 ConvaTec Group plc
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Smith & Nephew plc
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Terumo Corporation
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 SkinSmart Solutions
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Halyard Health, Inc.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Cardinal Health, Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Teleflex Incorporated
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Hollister Incorporated
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Adapta Medical Solutions
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Wound Care Technologies, Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 BD (Becton, Dickinson and Company)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Intravenous Securement Device Sales Market, By Application
    • 6.1.1 Hospitals
    • 6.1.2 Ambulatory Surgical Centers
    • 6.1.3 Clinics
    • 6.1.4 Homecare Settings
    • 6.1.5 Others
  • 6.2 Intravenous Securement Device Sales Market, By Product Type
    • 6.2.1 Adhesive Securement Devices
    • 6.2.2 Mechanical Securement Devices
    • 6.2.3 Integrated Securement Devices
    • 6.2.4 Securement Strips
    • 6.2.5 Securement Dressings
  • 6.3 Intravenous Securement Device Sales Market, By Material Type
    • 6.3.1 Silicone
    • 6.3.2 Polyurethane
    • 6.3.3 Acrylic
    • 6.3.4 Others
  • 6.4 Intravenous Securement Device Sales Market, By Distribution Channel
    • 6.4.1 Direct Sales
    • 6.4.2 Distributors

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Intravenous Securement Device Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Intravenous Securement Device Sales market is categorized based on

By Product Type

• Adhesive Securement Devices
• Mechanical Securement Devices
• Integrated Securement Devices
• Securement Strips
• Securement Dressings

By Application

• Hospitals
• Ambulatory Surgical Centers
• Clinics
• Homecare Settings
• Others

By Distribution Channel

• Direct Sales
• Distributors

By Material Type

• Silicone
• Polyurethane
• Acrylic
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• 3M Company
• Smith & Nephew plc
• BD (Becton, Dickinson and Company)
• Medtronic plc
• Teleflex Incorporated
• Fresenius Kabi AG
• Terumo Corporation
• Braun Melsungen AG
• Hollister Incorporated
• ConvaTec Group plc
• SkinSmart Solutions
• Halyard Health, Inc.
• Cardinal Health, Inc.
• Wound Care Technologies, Inc.
• Adapta Medical Solutions